Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double blind, placebo controlled, 2-way cross-over study in adults with non-allergic rhinitis to evaluate the effect of once daily administration of intranasal SB-705498 12mg for two weeks and the response to a chamber challenge of cold dry air
SB705498
VR1114974
NCT01424514
Rhinitis
Phase 2
 
November 2014

Powered by ideaPoint, Inc.